Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
5228 | 1585 | 33.4 | 58% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1268 | 8357 | ADRENOMEDULLIN//AMYLIN//ISLET AMYLOID POLYPEPTIDE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CALCITONIN | Author keyword | 52 | 19% | 16% | 250 |
2 | SALMON CALCITONIN | Author keyword | 31 | 35% | 5% | 73 |
3 | CALCITONIN RECEPTOR | Author keyword | 23 | 43% | 3% | 40 |
4 | CALCITONIN RECEPTOR STIMULATING PEPTIDE | Author keyword | 8 | 75% | 0% | 6 |
5 | SALMON CALCITONIN NASAL SPRAY | Author keyword | 6 | 100% | 0% | 4 |
6 | HUMAN CALCITONIN | Author keyword | 5 | 29% | 1% | 15 |
7 | NASAL SALMON CALCITONIN | Author keyword | 4 | 67% | 0% | 4 |
8 | CALCITONIN RECEPTORS | Author keyword | 4 | 56% | 0% | 5 |
9 | HYPOCALCEMIC ACTIVITY | Author keyword | 4 | 56% | 0% | 5 |
10 | EEL CALCITONIN | Author keyword | 3 | 57% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CALCITONIN | 52 | 19% | 16% | 250 | Search CALCITONIN | Search CALCITONIN |
2 | SALMON CALCITONIN | 31 | 35% | 5% | 73 | Search SALMON+CALCITONIN | Search SALMON+CALCITONIN |
3 | CALCITONIN RECEPTOR | 23 | 43% | 3% | 40 | Search CALCITONIN+RECEPTOR | Search CALCITONIN+RECEPTOR |
4 | CALCITONIN RECEPTOR STIMULATING PEPTIDE | 8 | 75% | 0% | 6 | Search CALCITONIN+RECEPTOR+STIMULATING+PEPTIDE | Search CALCITONIN+RECEPTOR+STIMULATING+PEPTIDE |
5 | SALMON CALCITONIN NASAL SPRAY | 6 | 100% | 0% | 4 | Search SALMON+CALCITONIN+NASAL+SPRAY | Search SALMON+CALCITONIN+NASAL+SPRAY |
6 | HUMAN CALCITONIN | 5 | 29% | 1% | 15 | Search HUMAN+CALCITONIN | Search HUMAN+CALCITONIN |
7 | NASAL SALMON CALCITONIN | 4 | 67% | 0% | 4 | Search NASAL+SALMON+CALCITONIN | Search NASAL+SALMON+CALCITONIN |
8 | CALCITONIN RECEPTORS | 4 | 56% | 0% | 5 | Search CALCITONIN+RECEPTORS | Search CALCITONIN+RECEPTORS |
9 | HYPOCALCEMIC ACTIVITY | 4 | 56% | 0% | 5 | Search HYPOCALCEMIC+ACTIVITY | Search HYPOCALCEMIC+ACTIVITY |
10 | EEL CALCITONIN | 3 | 57% | 0% | 4 | Search EEL+CALCITONIN | Search EEL+CALCITONIN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SALMON CALCITONIN | 87 | 31% | 15% | 238 |
2 | ESTABLISHED OSTEOPOROSIS | 39 | 41% | 5% | 73 |
3 | ISOLATED RAT OSTEOCLASTS | 30 | 49% | 3% | 45 |
4 | EEL CALCITONIN | 22 | 66% | 1% | 21 |
5 | PORCINE CALCITONIN | 21 | 85% | 1% | 11 |
6 | NASAL SALMON CALCITONIN | 16 | 61% | 1% | 17 |
7 | SALCATONIN | 15 | 67% | 1% | 14 |
8 | RAT OSTEOCLASTS | 11 | 19% | 3% | 52 |
9 | INTRANASAL CALCITONIN | 10 | 63% | 1% | 10 |
10 | NASAL CALCITONIN | 9 | 83% | 0% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Salmon calcitonin: a review of current and future therapeutic indications | 2008 | 58 | 85 | 62% |
Calcitonin | 1999 | 107 | 279 | 61% |
Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis | 2002 | 69 | 56 | 86% |
Calcitonin for treating acute and chronic pain of recent and remote osteoporotic vertebral compression fractures: a systematic review and meta-analysis | 2012 | 14 | 49 | 63% |
Salmon Calcitonin Use and Associated Cancer Risk | 2013 | 8 | 34 | 47% |
Forty years of calcitonin - Where are we now? A tribute to the work of Iain Macintyre, FRS | 2002 | 80 | 144 | 58% |
Lessons Learned From the Development of Oral Calcitonin: The First Tablet Formulation of a Protein in Phase III Clinical Trials | 2011 | 25 | 64 | 33% |
Molecular pharmacology of the calcitonin receptor | 2002 | 53 | 107 | 64% |
Molecular physiology and pharmacology of calcitonin | 2006 | 15 | 121 | 60% |
Calcitonin is involved in cartilage homeostasis: Is calcitonin a treatment for OA? | 2006 | 22 | 72 | 44% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLIN DEV SURVEILLANCE | 2 | 67% | 0.1% | 2 |
2 | MED 1 MED PATHOL CLIN METHODOL | 2 | 67% | 0.1% | 2 |
3 | INTERNAL MED RHEUMATOL OSTEOL 2 | 1 | 38% | 0.2% | 3 |
4 | GERIATR MED EXTENDED CARE SERV | 1 | 100% | 0.1% | 2 |
5 | INTERATENEO FIS | 1 | 100% | 0.1% | 2 |
6 | MED BIOCHEM MED BONE UNIT | 1 | 100% | 0.1% | 2 |
7 | ORTHOPED SURG CALCIUM METAB | 1 | 50% | 0.1% | 2 |
8 | SKELETAL AGING OSTEOPOROSIS | 1 | 100% | 0.1% | 2 |
9 | MT SINAI BONE PROGRAM | 1 | 11% | 0.6% | 10 |
10 | HIGH ENERGY MED | 1 | 40% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000162793 | C CELLS//TT CELLS//CALCITONIN SECRETION |
2 | 0.0000109252 | THORACIC DUCT DRAINAGE//CD4 SUPPRESSOR T CELL//GUSPERIMUS HYDROCHLORIDE |
3 | 0.0000106617 | DIETARY CA RESTRICTION//ZURICH OSTEOPOROSIS GRP//1 ALPHA HYDROXYVITAMIN D 3 |
4 | 0.0000080595 | HYPOTYROIDISM//LIBERINS//UNSOLVABLE PROBLEMS |
5 | 0.0000079682 | CALCITONIN GENE RELATED PEPTIDE//CALCITONIN GENE RELATED PEPTIDE CGRP//CGRP CALCITONIN GENE RELATED PEPTIDE |
6 | 0.0000079373 | IPRIFLAVONE//TAK 778//ULMUS WALLICHIANA |
7 | 0.0000065648 | STANNIOCALCIN 1//STANNIOCALCIN//CORPUSCLES OF STANNIUS |
8 | 0.0000062654 | EMBRYONIC AUTOREGULATIONS//ENDOGENOUS AMINO COMPOUNDS//CHICK MESONEPHROS |
9 | 0.0000062516 | BONE FLUORIDE CONTENT//CAS 10163 15 2//MONOFLUOROPHOSPHATE |
10 | 0.0000051115 | RANKL//OSTEOCLAST//OSTEOCLASTOGENESIS |